Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Hepatology International

Issue Special Issue 2/2013

Special Supplement: Nonalcoholic Fatty Liver Disease

Content (10 Articles)

Review Article

Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)

Ajay Duseja, Naga Chalasani

Review Article

Current histological classification of NAFLD: strength and limitations

Pierre Bedossa

Open Access Review Article

Immune and inflammatory pathways in NASH

Michal Ganz, Gyongyi Szabo

Open Access Review Article

Insulin resistance, steatosis and hepatitis C virus

Alessandra Mangia, Maria Ripoli

Review Article

Hard clinical outcomes in patients with NAFLD

Ramesh Kumar

Review Article

An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis

Arun J. Sanyal

Review Article

Lean NASH: distinctiveness and clinical implication

Kausik Das, Abhijit Chowdhury

Review Article

Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH

Luca Montesi, Arianna Mazzotti, Simona Moscatiello, Gabriele Forlani, Giulio Marchesini

Review Article

Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific

Roslyn Vongsuvanh, David van der Poorten, Jacob George

Review Article

Pharmacological agents for nonalcoholic steatohepatitis

Maeva Guillaume, Vlad Ratziu

Oct 13
Issue: 4/2013
Jan 14
Issue: 1/2014

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits